Log In
Print
BCIQ
Print
Print this Print this
 

Trokendi XR, topiramate (formerly SPN-538)

  Manage Alerts
Collapse Summary General Information
Company Supernus Pharmaceuticals Inc.
DescriptionExtended release formulation of topiramate
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationEpilepsy
Indication DetailsTreat epilepsy
Regulatory Designation

U.S. - Standard Review (Treat epilepsy)

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today